Nanotech Security to Seek Regulatory Approval to Upsize Subscription Receipts Financing

Nanotech Security Corp. (the “Company”), developer of next-generation security and authentication features using patented nano-optics announces that further to its news release of August 1, 2013, the Company will be seeking regulatory approval to upsize the Subscription Receipts financing from $3 million to a maximum of $4 million.

The Subscription Receipts are convertible into equity units comprised of one common share and one-half common share purchase warrant which automatically convert into units upon completion of the acquisition of two patent holding corporations as described in the August 1st release. The terms of that acquisition are clarified in two respects, firstly that the deemed value of the escrowed shares to be issued is $0.72 and secondly that the escrow will allow for 25% semi-annual releases over the two years from closing starting six months from closing. Both the financing and acquisition transactions remain subject to execution of definitive agreements and TSX Venture Exchange acceptance, although the financing transaction has received conditional approval at this time.

There is one insider who participated in this financing and four members of a “Pro Group” as defined in the Rules of the Exchange.

For additional information about Nanotech Security’s KolourOptiks® nano-technology, visit http://vimeo.com/nanotechsecurity. More information about the Company can be found at the Company’s website www.nanosecurity.ca or www.sedar.com

On Behalf of the Board of Directors of

Nanotech Security Corp.

“Doug H. Blakeway”

President and CEO

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.